HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality.

AbstractOBJECTIVE:
The purpose of this, open-label, non-comparative study, was to evaluate the efficacy on quality of life and the efficacy of gabapentin monotherapy in patients with chronic radiculopathy.
METHODS:
Thirty-five patients with radicular pain and diagnosed as L4, L5 or S1 radiculopathy were treated with oral gabapentin from a total of 300 mg per day once up to a total of 1800 mg per day divided in 3 doses for eight-week trial period. Quality of life, functional disability and psychological mood of the patients were assessed using the Nottingham Healthy Profile (NHP), Oswestry Low Back Pain Disability Questionnaire (ODQ) and Beck Depression Inventory (BDI).
RESULTS:
Of the patients (n = 35), 25 were females and 10 were males (mean age: 41.8 +/- 10.4, range: 24-60 years); mean radiculopathy duration was 16.4 +/- 14.2 months (range: 3-48 months). The pain intensity at rest, quality of life, functional disability and depression scores were determined significantly improved after treatment and 4 months compared to baseline scores (p < 0.001). 1.5 points compared to baseline for at pain rest and 15 points improvement on the ODQ were obtained.
CONCLUSION:
Gabapentin may provide benefits in terms of alleviation of pain and overall quality of life in patients with chronic radiculopathy.
AuthorsKadir Yildirim, Orhan Deniz, Gurhan Gureser, Saliha Karatay, Mahir Ugur, Akin Erdal, Kazim Senel
JournalJournal of back and musculoskeletal rehabilitation (J Back Musculoskelet Rehabil) Vol. 22 Issue 1 Pg. 17-20 ( 2009) ISSN: 1878-6324 [Electronic] Netherlands
PMID20023359 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Amines
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin
Topics
  • Administration, Oral
  • Adult
  • Amines (administration & dosage, therapeutic use)
  • Anticonvulsants (administration & dosage, therapeutic use)
  • Chronic Disease
  • Cyclohexanecarboxylic Acids (administration & dosage, therapeutic use)
  • Depression (etiology)
  • Disability Evaluation
  • Female
  • Gabapentin
  • Humans
  • Low Back Pain (etiology)
  • Male
  • Middle Aged
  • Pain Measurement
  • Quality of Life (psychology)
  • Radiculopathy (complications, drug therapy, psychology)
  • Treatment Outcome
  • gamma-Aminobutyric Acid (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: